ESMO Targeted Anticancer Therapies Congress 2022
March 7 - March 8, 2022
Speaker/Participant: Hans J. Van der Vliet, M.D., Ph.D., Chief Scientific Officer, LAVA Therapeutics
Presentation: Bispecifics and T-cell Engagers session presentation – “Bispecific γδ-T cell engagers for the treatment of cancer”
Presentation Location: Channel 1 virtual room
Presentation Date: Monday, 7 March 2022
Presentation Time: 14.15 – 15.30 CET
Supporting Materials
ESMO-TAT-2022.pdf 13.6 MB
Location
San Diego